Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
Abstract Purpose Immunotherapy has emerged as a novel therapy, while many patients are refractory. Although, several biomarkers have been identified as predictive biomarkers for immunotherapy, such as tumor specific genes, PD-1/PD-L1, tumor mutation burn (TMB), and microsatellite instability (MSI),...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Springer
2022-07-01
|
| Seria: | Discover Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1007/s12672-022-00528-8 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|